Aristides Capital’s Accendra Health ACH Stock Holding History

Aristides Capital’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-66,800	Closed	-$187K	–	250
2025 Q4	$187K	Buy	+66,800	New	+$239K	0.03%	199

Other funds holding ACH

CCM

Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aristides Capital's ACH Position: Q1 2026 in Review

Aristides Capital sold out of Accendra Health (ACH) in Q1 2026, closing a stake of 66,800 shares — an estimated $187K sold.

Aristides Capital first reported a position in ACH in Q4 2025 and held it in 1 quarter. The position peaked at $187K in Q4 2025. 142 funds tracked by Wall St. Rank hold ACH as of Q1 2026.

Aristides Capital reported no remaining Accendra Health position as of Q1 2026 after selling out during the quarter.
Aristides Capital sold 66,800 Accendra Health shares in Q1 2026, an estimated $187K.
Aristides Capital first reported a position in Accendra Health in Q4 2025 and held it in 1 quarter.
Aristides Capital's Accendra Health position peaked at $187K in Q4 2025.
142 funds tracked by Wall St. Rank held Accendra Health as of Q1 2026.

Based on Aristides Capital's 13F filing for Q1 2026, filed 14 May 2026.